Outsourcing Against the Outbreak Episodes

1. Expanding Global Access Through Voluntary Licensing and Tech Transfer 8/25/2026

   Turning patented biomedical discoveries into affordable, widely available treatments requires aligned partnerships between innovator pharma and regional generic manufacturers. In this episode of Outsourcing Against the Outbreak, Charles Gore, Executive Director of the Medicines Patent Pool (MPP), breaks down how voluntary licensing models expand access across low- and middle-income markets.

2. Advancing Academic Vaccine Innovation into Global Access 8/25/2026

   Moving infectious disease programs from promising laboratory discoveries to scalable interventions requires bridging the gap between academic research and commercial manufacturing. In this episode of Outsourcing Against the Outbreak, Dr. Maria Elena Bottazzi, Co-Director of the Texas Children's Hospital Center for Vaccine Development at Baylor College of Medicine, explores how academic teams can navigate this journey successfully.

3. Great Science Isn't Enough: Solving The Global Health Drug Development Equation 8/25/2026

   Designing infectious disease interventions for low- and middle-income countries requires solving for access, affordability, and delivery from day one rather than treating them as downstream afterthoughts. In this inaugural episode of Outsourcing Against the Outbreak, Dr. Krishnan Ramanathan, Interim CEO of the Gates Medical Research Institute (Gates MRI), explores how to navigate the unique economic and operational realities of global health R&D.